SANOFI Share Price Swiss Exchange
Stocks
SASY
FR0000120578
Pharmaceuticals
OTC Markets Traded
| Market Cap | 88.98B 102B 82.41B 77.15B 145B 9,630B 146B 978B 379B 4,740B 383B 375B 16,459B | P/E 2026 * |
11x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 99.79B 114B 92.42B 86.52B 162B 10,799B 163B 1,096B 425B 5,315B 430B 420B 18,457B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.94x |
| Free-Float |
89% | Yield 2026 * |
5.74% | Yield 2027 * | 6.08% |
Last Transcript: SANOFI
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 30/04/2026 | |
| Director of Finance/CFO | 64 | 31/03/2024 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 10/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 29/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 27/04/2020 |
Lise Kingo
BRD | Director/Board Member | 64 | 27/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 102B | |
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | |
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | |
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | |
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | |
| Average | -0.27% | -3.02% | +20.11% | +40.03% | 366.93B | |
| Weighted average by Cap. | -0.76% | -3.68% | +29.49% | +63.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.07B 53.98B 43.59B 40.81B 76.53B 5,094B 77B 517B 200B 2,507B 203B 198B 8,706B | 49.98B 57.32B 46.29B 43.33B 81.27B 5,409B 81.76B 549B 213B 2,662B 215B 211B 9,244B |
| Net income | 8.15B 9.34B 7.54B 7.06B 13.24B 881B 13.32B 89.49B 34.68B 434B 35.07B 34.31B 1,507B | 8.95B 10.27B 8.29B 7.76B 14.56B 969B 14.65B 98.39B 38.13B 477B 38.55B 37.73B 1,656B |
| Net Debt | 10.8B 12.39B 10.01B 9.37B 17.57B 1,169B 17.67B 119B 46B 575B 46.51B 45.51B 1,998B | 8.08B 9.27B 7.49B 7.01B 13.14B 875B 13.22B 88.81B 34.42B 431B 34.8B 34.05B 1,495B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
